1)Goldsmith LA, et al:Fitzpatrick's Dermatology in General Medicine, p2715, 8th ed, McGraw Hill, 2012
2)Rhen T, Cidlowski JA:Antiinflammatory action of glucocorticoids;New mechanisms for old drugs. N Engl J Med 353:1711-1723, 2005
3)Buttgereit F, et al:Standardised nomenclature for glucocorticoid dosages and glucocorticoid treatment regimens;Current questions and tentative answers in rheumatology. Ann Rheum Dis 61:718-722, 2002
4)日本アレルギー学会喘息ガイドライン専門部会(監),喘息予防・管理ガイドライン2015作成委員(作成):喘息予防・管理ガイドライン2015,協和企画,2015
5)Walsh TJ et al;Infectious Diseases Society of America. Treatment of aspergillosis;Clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis 46:327-360, 2008
6)Kim S, et al:Influence of initial treatment modality on long-term control of chronic idiopathic urticaria. PLoS ONE 8:e69345, 2013
7)Lee JM, Greenes DS:Biphasic anaphylactic reactions in pediatrics. Pediatrics 106:762-766, 2000
8)Choo KJ, et al:Glucocorticoids for the treatment of anaphylaxis. Cochrane Database Syst Rev(4):CD007596, 2012
9)Halebian PH, et al:Improved burn center survival of patients with toxic epidermal necrolysis managed without corticosteroids. Ann Surg 204:503-512, 1986
10)Goldsmith LA, et al:Fitzpatrick's Dermatology in General Medicine, p180, 8th ed, McGraw Hill, 2012
11)Dellon ES, Liacouras CA:Advances in clinical management of eosinophilic esophagitis. Gastroenterology 147:1238-1254, 2014
12)Kagalwalla AF, et al;Eosinophilic esophagitis;Epithelial mesenchymal transition contributes to esophageal remodeling and reverses with treatment. J Allergy Clin Immunol 129:1387-1396, 2012
13)Schaefer ET, et al:Comparison of oral prednisone and topical fluticasone in the treatment of eosinophilic esophagitis;A randomized trial in children. Clin Gastroenterol Hepatol 6:165, 2008